Publication:
How the Addition of Hormones Improves Outcome: Hormone Therapy and Chemotherapy

Issued Date

2004-01-01

Resource Type

Conference Paper

ISSN

15699056

DOI

10.1016/j.eursup.2003.12.009

Other identifier(s)

2-s2.0-1042289549

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

European Urology, Supplements. Vol.3, No.1 (2004), 37-39

Suggested Citation

Wachira Kochakarn How the Addition of Hormones Improves Outcome: Hormone Therapy and Chemotherapy. European Urology, Supplements. Vol.3, No.1 (2004), 37-39. doi:10.1016/j.eursup.2003.12.009 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21746

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

How the Addition of Hormones Improves Outcome: Hormone Therapy and Chemotherapy

Author(s)

Wachira Kochakarn

Other Contributor(s)

Mahidol University

Abstract

Chemotherapy alone for the treatment of hormone-resistant prostate cancer is associated with very poor objective response rates of less than 10%. No single agent or regimen has thus far shown a consistent impact on survival. As a result, there is no standard regimen and new agents and combinations are continually being investigated. In theory, it may be beneficial to start chemotherapy earlier in the disease, while the patient is still responding to hormonal therapy but when their PSA is already starting to rise. © 2004 Elsevier B.V. All rights reserved.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/21746

Collections

Scopus 2001-2005